510(k) K260213
K260213 is an FDA 510(k) premarket notification submitted by BD Diagnostic Systems for the device "BD BACTEC FXI Culture System". The FDA issued a decision of Substantially Equivalent on May 28, 2026. The device falls under product code MDB (System, Blood Culturing), a Class I device regulated under 21 CFR 866.2560. BD Diagnostic Systems has at least 5 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 28, 2026
- Date Received
- January 23, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- System, Blood Culturing
- Device Class
- Class I
- Regulation Number
- 866.2560
- Review Panel
- MI
- Submission Type